WO2003038440A3 - Chemokine binding molecules - Google Patents

Chemokine binding molecules Download PDF

Info

Publication number
WO2003038440A3
WO2003038440A3 PCT/GB2002/004918 GB0204918W WO03038440A3 WO 2003038440 A3 WO2003038440 A3 WO 2003038440A3 GB 0204918 W GB0204918 W GB 0204918W WO 03038440 A3 WO03038440 A3 WO 03038440A3
Authority
WO
WIPO (PCT)
Prior art keywords
binding molecules
chemokine binding
proteins
diseases
chemokine
Prior art date
Application number
PCT/GB2002/004918
Other languages
French (fr)
Other versions
WO2003038440A2 (en
Inventor
Antonio Alcami
Neil Bryant
Nicholas Davis-Poynter
Original Assignee
Univ Cambridge Tech
Animal Health Trust
Antonio Alcami
Neil Bryant
Nicholas Davis-Poynter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cambridge Tech, Animal Health Trust, Antonio Alcami, Neil Bryant, Nicholas Davis-Poynter filed Critical Univ Cambridge Tech
Priority to AU2002337342A priority Critical patent/AU2002337342A1/en
Publication of WO2003038440A2 publication Critical patent/WO2003038440A2/en
Publication of WO2003038440A3 publication Critical patent/WO2003038440A3/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869Interleukin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Abstract

The present invention relates to a family of glycoproteins found in alphaherpesviruses (gG proteins) which bind chemokines and impair their biological function. Methods and means relating to the use of gG proteins in the treatment of diseases, in particular chemokine-mediated diseases, are provided.
PCT/GB2002/004918 2001-10-30 2002-10-30 Chemokine binding molecules WO2003038440A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002337342A AU2002337342A1 (en) 2001-10-30 2002-10-30 Chemokine binding molecules

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0126047.0A GB0126047D0 (en) 2001-10-30 2001-10-30 Therapeutic molecules
GB0126047.0 2001-10-30

Publications (2)

Publication Number Publication Date
WO2003038440A2 WO2003038440A2 (en) 2003-05-08
WO2003038440A3 true WO2003038440A3 (en) 2003-12-31

Family

ID=9924806

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2002/004918 WO2003038440A2 (en) 2001-10-30 2002-10-30 Chemokine binding molecules

Country Status (3)

Country Link
AU (1) AU2002337342A1 (en)
GB (1) GB0126047D0 (en)
WO (1) WO2003038440A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2429639B1 (en) * 2012-04-11 2014-09-11 Consejo Superior De Investigaciones Científicas (Csic) Glycosaminoglycan binding of proteins with SECRET domain encoded by poxvirus

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987000862A1 (en) * 1985-07-29 1987-02-12 The Upjohn Company Virus vaccine
WO1990013652A1 (en) * 1989-05-12 1990-11-15 Triton Diagnostics, Inc. Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
WO1995022607A1 (en) * 1994-02-17 1995-08-24 Syntro Corporation Recombinant equine herpesviruses
US5922327A (en) * 1992-06-01 1999-07-13 The University Of Melbourne Equine herpes virus glycoproteins

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987000862A1 (en) * 1985-07-29 1987-02-12 The Upjohn Company Virus vaccine
WO1990013652A1 (en) * 1989-05-12 1990-11-15 Triton Diagnostics, Inc. Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
US5922327A (en) * 1992-06-01 1999-07-13 The University Of Melbourne Equine herpes virus glycoproteins
WO1995022607A1 (en) * 1994-02-17 1995-08-24 Syntro Corporation Recombinant equine herpesviruses

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BRYANT NEIL A ET AL: "Glycoprotein G isoforms from some alphaherpesviruses function as broad-spectrum chemokine binding proteins.", THE EMBO JOURNAL. ENGLAND 17 FEB 2003, vol. 22, no. 4, 17 February 2003 (2003-02-17), pages 833 - 846, XP002256205, ISSN: 0261-4189 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1993, KIT SAUL ET AL: "Circumvention of maternal antibody interference by immunization of newborn pigs with glycoprotein gIII-deleted marker vaccine.", XP002256206, Database accession no. PREV199497031172 *
IMMUNOLOGY AND CELL BIOLOGY, vol. 71, no. 5, 1993, pages 421 - 430, ISSN: 0818-9641 *
MILNE R S ET AL: "RANTES binding and down-regulation by a novel human herpesvirus-6 beta chemokine receptor.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD.: 1950) UNITED STATES 1 MAR 2000, vol. 164, no. 5, 1 March 2000 (2000-03-01), pages 2396 - 2404, XP002256204, ISSN: 0022-1767 *
PARRY C M ET AL: "A BROAD SPECTRUM SECRETED CHEMOKINE BINDING PROTEIN ENCODED BY A HERPESVIRUS", JOURNAL OF EXPERIMENTAL MEDICINE, TOKYO, JP, vol. 3, no. 7, 7 February 2000 (2000-02-07), pages 573 - 578, XP000982193, ISSN: 0022-1007 *
TRAN LORREN C ET AL: "A herpes simplex virus 1 recombinant lacking the glycoprotein G coding sequences is defective in entry through apical surfaces of polarized epithelial cells in culture and in vivo.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 97, no. 4, 15 February 2000 (2000-02-15), Feb. 15, 2000, pages 1818 - 1822, XP002256203, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
WO2003038440A2 (en) 2003-05-08
GB0126047D0 (en) 2001-12-19
AU2002337342A1 (en) 2003-05-12

Similar Documents

Publication Publication Date Title
WO2003057134A3 (en) Specific binding agents of human angiopoietin-2
WO2004092215A3 (en) Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
WO2003087138A3 (en) Methods for identifying polypeptide factors interacting with rna
AU2002303719A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002324458A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
EP1414844A4 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
WO2003038440A3 (en) Chemokine binding molecules
WO2003099863A3 (en) Resistin binding proteins, their preparation and use
AU2002327214A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002324475A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002322317A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002257117A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002243459A1 (en) Isolated human phosphodiesterase proteins, nucleic acid molecules encoding human phosphodiesterase proteins, and uses thereof
WO2003006605A9 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002326351A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002324499A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002305843A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins and uses thereof
EP1404826A4 (en) Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
AU2002305909A1 (en) Isolated human transporter protein, nucleic acid molecules encoding human transporter protein, and uses thereof
AU2002354554A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002316389A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002322446A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
WO2002077260A9 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002257266A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002338582A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP